The new weight loss drugs represent a breakthrough in treatment, giving hope to millions of individuals struggling with obesity, provided they can access them.
The Obesity Health Alliance highlights that chronic underfunding and workforce challenges within NHS obesity services hinder equitable access to weight loss injections.
Doctors warn that some patients need to wait up to five years for specialist support, leading to services becoming overstretched and closing waiting lists.
The estimated number of people eligible for Wegovy significantly surpasses NHS projections for those who will actually receive the treatment by 2028.
Collection
[
|
...
]